Strong systems that enable trust and governance are key to enabling the growth of AI technologies in drug development.

Bringing a single drug to market can take more than a decade and cost billions of dollars, with fewer than one in ten candidates successfully reaching approval. Against this backdrop, generative AI is ...

Neuroscience trials require high-precision, sensitive endpoint measurements, yet sponsors often face challenges with ...

Simulations Plus Inc (NASDAQ:SLP) is among the best medical AI stocks to buy now. On March 26, Simulations Plus announced ...

Novo Nordisk on Tuesday announced a partnership with OpenAI to deploy artificial intelligence across its business, spanning ...

On April 22, researchers introduced two separate AI tools aimed at easing persistent challenges in drug development. A University of Oregon team developed a model that uses AI and physics data to ...

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...

The US Food and Drug Administration (FDA) has released a new draft guidance on the use of artificial intelligence (AI) that produces data or information that supports regulatory decision-making in ...

As multiple other organizations are joining Google cloud amid Artificial Intelligence AI technology push. Drugmaker Merck & ...

Artificial intelligence is revolutionizing medical science through cutting-edge diagnosis and AI-powered tools. Now, AI is ...

Simulations Plus Inc (NASDAQ:SLP) is among the best medical AI stocks to buy now. On March 26, Simulations Plus announced ...